Toward new camptothecins. Part 4: On the reactivity of nitro and amino precursors of aza analogs of 5-methoxycarbonyl camptothecin

Tetrahedron

Volumn 63, Issue 38, 2007, Pages 9456-9464

  Gavara, Laurent ^a   Rigo, Benoît ^a   Couturier, Daniel ^b   Goossens, Laurence ^c   Hénichart, Jean Pierre ^c  

^a Ecole des Hautes Etudes d'Ingenieur   (France)

^b UNIV LILLE   (France)

^c Faculté des Sciences Pharmaceutiques et Biologiques Université de Lille   (France)

Author keywords

2 Pyridone; Camptothecin; Decarboxylation; Nitro displacement

Indexed keywords

AMINE; CAMPTOTHECIN DERIVATIVE; HETEROCYCLIC COMPOUND; HYDROBROMIC ACID; NITRO DERIVATIVE; PYRROLE DERIVATIVE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; DRUG SYNTHESIS; NITRATION; NUCLEAR OVERHAUSER EFFECT; OXIDATION; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS;

EID: 34547683718     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.06.083     Document Type: Article

References (67)

1. Smith D. In: Sammes P.G. (Ed). Comprehensive Organic Chemistry Vol. 4 (1979), Pergamon, Oxford 3
2. Bailey T., Goe G., and Scriven E. In: Newkome G.R. (Ed). Heterocyclic Compounds Vol. 14 (1984), Wiley, New York, NY 1 Part 5
3. McKillop A., and Boulton A. In: McKillop A., and Boulton A. (Eds). Comprehensive Heterocyclic Chemistry Vol. 2 (1984), Pergamon, Oxford 67
4. Pendrack I., Wittrock R., and Kingbury W. J. Org. Chem. 60 (1995) 2912
5. Parreira R.L.T., Abrahao O., and Galembeck S.E. Tetrahedron 57 (2001) 3243
6. Saari W.S., Hoffman J.M., Wai J.S., Fisher T.E., Rooney C.S., Smith A.M., Thomas C.M., Goldman M.E., and O'Brien J.A. J. Med. Chem. 34 (1991) 2922
7. Basf Aktiengesellschaft. PCT Int. Appl. WO 2002006233, 2002;
8. Chem. Abstr. 136 (2002) 118386
9. Imperial Chemical Industries PLC. Eur. Pat. Appl. EP 259048, 1988;
10. Chem. Abstr. 109 (1988) 73348
11. Matsumoto M., and Minato H. Tetrahedron Lett. 42 (1976) 3827
12. Cox R., and O'Hagan D. J. Chem. Soc., Perkin Trans. 1 (1991) 2537
13. Sumitomo Chemical Co. Eur. Pat. Appl. EP 535980, 1993;
14. Chem. Abstr. 119 (1993) 117126
15. Williams D.R., Lowder P.D., and Gu Y.-G. Tetrahedron Lett. 38 (1997) 327
16. Brickner S. Chem. Ind. (1997) 131
17. Seto, H.; Hayakawa, Y.; Shimazu, A. Jpn. Kokai Tokkyo Koho, JP 05306272, 1993.
18. Yuldashev P.K. Chem. Nat. Compd. 37 (2001) 274
19. Kozikowski A.P., Campiani G., Sun L.-Q., Wang S., Saxena A., and Doctor B.P. J. Am. Chem. Soc. 118 (1991) 11357
20. Wall M.E., Wani M.C., Cook C.E., Palmer K.H., McPhail A.I., and Sim G.A. J. Am. Chem. Soc. 88 (1966) 3888
21. Schultz A.G. Chem. Rev. 73 (1973) 365
22. Hutchinson C.R. Tetrahedron 37 (1981) 1047
23. In: Tang W., and Eisenbrand G. (Eds). Chinese Drugs of Plant Origin (1992), Springer, New York, NY 239
24. Ciufolini M.A., and Roschangar F. Targets Heterocycl. Syst. 4 (2000) 25
25. Kim D.-K., and Lee N. Min. Rev. Med. Chem. 2 (2002) 611
26. Lerchen H.G. Drugs Future 27 (2002) 869
27. Ulukan H., and Swan P.W. Drugs 62 (2002) 2039
28. Du W. Tetrahedron 59 (2003) 8649
29. Lee K.H. J. Nat. Prod. 67 (2004) 273
30. Craig J.T., Rahier N.J., and Hecht S.M. Bioorg. Med. Chem. 12 (2004) 1585
31. Ciufolini M.A., and Roschangar F. Tetrahedron 53 (1997) 11049
32. Schultz A. Chem. Rev. 73 (1973) 1047
33. Hutchinson C.R. Tetrahedron 37 (1981) 1047
34. Lavelle F., Bissery M.C., André S., Roquet F., and Riou J.F. Semin. Oncol. 23 (1996) 13
35. Rothenberg, M. L.; Rowinsky, E. K.; Kuhn, J. G.; Burris, H. A.; Donehower, R. C.; Vonhoff, D. D. Camptothecins: New Anticancer Agents; Potmesil, M., Pinedo, H., Eds.; CRC: Boca Raton, FL, 1995; p 75;
36. Santos A., Zanetta S., Cresteil T., Debroussent A., Pein F., Raymont E., Vernillet L., Rise M., Bioige V., Gaugette A., and Vassal G. Clin. Cancer Res. 6 (2000) 2012
37. Staker B.L., Feese M.D., Cushman M., Pommier Y., Zembower D., Stewart L., and Burgin A.B. J. Med. Chem. 48 (2005) 2336
38. Staker B.L., Hjerrild K., Feese M.D., Behnke C.A., Burgin A.B., and Stewart L. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 15387
39. Sugimori M., Ejima A., Ohuki S., Uoto K., Mitsui I., Matsumoto K., Kawato Y., Yasuoka M., Sato K., Tagawa H., and Terasawa H. J. Med. Chem. 37 (1994) 3033
40. Luzzio M.J., Besterman J.M., Emerson D.L., Evans M.G., Lackey K., Leitner P.L., McIntyre G., Morton B., Myers P.L., Peel M., Sisco J.M., Sternbach D.D., Tong W.-Q., Truesdale A., Uehling D.E., Vuong A., and Yates Y. J. Med. Chem. 38 (1995) 395
41. Sugimori M., Ejima A., Ohsuki S., Uoto K., Mitsui I., Kawato Y., Hirota Y., Sato K., and Terasawa H. J. Med. Chem. 41 (1998) 2308
42. Lavergne O., Lesueur-Ginot L., Pla Rodas F., and Bigg D.C.H. Bioorg. Med. Chem. Lett. 7 (1997) 2235
43. Concerning this paradigm, see also:. Hautefaye P., Cimetière B., Pierre A., Léonce S., Hickman J., Laine W., Bailly C., and Lavielle G. Bioorg. Med. Chem. Lett. 13 (2003) 2731
44. Nicholas A., Wani M., Manikumar G., Wall M., Kohn K., and Pommier Y. J. Med. Chem. 33 (1990) 972
45. Lavergne O., Lesueur-Ginot L., Pla Rodas F., Kasprzyk P.G., Pommier J., Demarquay D., Prevost G., Ulibarri G., Rolland A., Schiano-Liberatoir A.M., Harnett J., Pons D., Camara J., and Biggs D.C.H. J. Med. Chem. 41 (1998) 5410
46. Lesueur-Ginot L., Demarquay D., Kiss R., Kasprzyk P.G., Dassonville L., Bailly C., Camara J., Lavergne O., and Biggs D.C. Cancer Res. 59 (1999) 2939
47. Philipart P., Harper L., and Chaboteaux C. Clin. Cancer Res. 6 (2000) 1557
48. Redinbo M.R., Steward L., Kuhn P., Champoux J.J., and Hol W.G.J. Science 279 (1998) 1504
49. Pommier Y. Nat. Rev. Cancer 6 (2006) 789
50. Cagir A. J. Am. Chem. Soc. 123 (2003) 13628
51. Brunin T., Hénichart J.-P., and Rigo B. Tetrahedron 61 (2005) 7916
52. Brunin T., Hénichart J.-P., Legentil L., and Rigo B. Tetrahedron 62 (2006) 3959
53. Malecki N., Houssin R., Hénichart J.-P., Couturier D., Petra F., Legentil L., and Rigo B. J. Heterocycl. Chem. 40 (2003) 45
54. Shen W., Coburn C., Bornmann W., and Danishefsky S. J. Org. Chem. 58 (1993) 611
55. Katritzky A., Scriven E., Majumder S., Akhmedova R., Akhmedov N., and Vakulenko A. Arkivoc (2005) 179
56. Schön R., and Weiland J. Steroids 62 (1997) 762
57. We have already described oxidation reaction encountered while heating compounds in aqueous hydrochloric or hydrobromic acid:. Akué-Gédu R., Bourry A., Camus F., Norberg B., Durant F., Couturier D., DeBacker M., and Rigo B. Heterocycles 63 (2004) 1855
58. Akué-Gédu, R.; Rigo, B. Targets Heterocycl. Syst., in press;
59. Tetrahedron Lett. 30 (1989) 7057
60. Tetrahedron Lett. 37 (1996) 485
61. Mashimov V.I. Tetrahedron 21 (1965) 687
62. Rapoport H. Lect. Heterocycl. Chem. IV (1978) S-47
63. Dragovich P., Zhou R., and Prins T. J. Org. Chem. 67 (2002) 741
64. Dragovich P. J. Med. Chem. 46 (2003) 4572
65. Zhang X., Schmitt A., and Decicco C. Tetrahedron Lett. 43 (2002) 9663
66. Aberg V., and Almqvist F. Bioorg. Med. Chem. 14 (2006) 7563
67. Millet R., Domarkas J., Rombaux P., Rigo B., Houssin R., and Hénichart J.-P. Tetrahedron Lett. 43 (2002) 5087